Rabies Post-Exposure Prophylaxis Guidelines

Standard Post-Exposure Prophylaxis Regimen

The Advisory Committee on Immunization Practices (ACIP) recommends a 4-dose schedule for rabies post-exposure prophylaxis in immunocompetent, previously unvaccinated persons, with 1.0 mL of HDCV or PCECV administered intramuscularly on days 0, 3, 7, and 14, and HRIG at 20 IU/kg on day 0 1, 2
The Centers for Disease Control and Prevention (CDC) guidelines state that the 4-dose regimen is adequate for rabies post-exposure prophylaxis in immunocompetent, previously unvaccinated persons, with a vaccine schedule of 1.0 mL of HDCV or PCECV administered intramuscularly on days 0, 3, 7, and 14 1, 2
The complete 4-dose protocol includes HRIG administration at 20 IU/kg body weight given once on day 0, infiltrated around and into the wound(s) if anatomically feasible, with any remaining volume injected intramuscularly at a site distant from vaccine administration, as recommended by the World Health Organization (WHO) 1, 2
The injection site for the vaccine is the deltoid muscle for adults and older children, and the anterolateral thigh for young children, according to the American Academy of Pediatrics (AAP) guidelines 1, 2

All healthy persons completing the 4-dose regimen demonstrate adequate antibody response (≥0.5 IU/mL) by day 14, with 100% seroprotection maintained through day 180, as reported by the National Institutes of Health (NIH) 1
Virus-neutralizing antibodies peak by approximately day 14-28 after starting vaccination, meaning protective immunity is established well before completion of the series, according to the CDC 3
Over 1,000 persons annually in the United States receive only 3 or 4 doses instead of the older 5-dose regimen, with no documented cases of rabies developing, even when >30% had confirmed exposure to rabid animals, as stated by the WHO 3

Immunocompromised patients require 5 doses (days 0, 3, 7, 14, and 28) plus HRIG at 20 IU/kg on day 0, even if previously vaccinated, as recommended by the Infectious Diseases Society of America (IDSA) 4, 3, 5
Previously vaccinated persons require only 2 doses (days 0 and 3) and do NOT need HRIG, according to the ACIP guidelines 1, 2, 4, 3, 5

Immediate wound care, including thorough washing with soap and water for 15 minutes, is perhaps the single most effective measure for preventing rabies, as stated by the WHO 4, 3
Passive immunity from HRIG provides immediate rabies virus-neutralizing antibody coverage during the first 7-10 days before vaccine-induced antibodies develop, according to the CDC 1, 2, 3
Active immunity from vaccine induces long-lasting antibody response that neutralizes rabies virus and prevents CNS invasion, as reported by the NIH 1

Never administer vaccine in the gluteal area, as this is associated with vaccine failure due to inadequate immune response, as warned by the AAP 4, 3
Never exceed 20 IU/kg of HRIG, as higher doses suppress active antibody production, according to the IDSA 4, 3
Never give HRIG in the same syringe or anatomical site as the vaccine, as recommended by the ACIP 1, 2, 4, 3
Never give HRIG to previously vaccinated persons (unless immunocompromised), as this critically impairs the memory immune response, as stated by the CDC 1, 2, 5

While adherence to the exact schedule is ideal, delays of a few days for individual doses are unimportant and do not compromise protection, according to the WHO 3
HRIG can be administered up to and including day 7 if it was not given initially on day 0, as recommended by the CDC 1, 2, 3

Routine post-vaccination antibody testing is unnecessary in immunocompetent individuals completing the 4-dose PEP regimen, as all healthy persons demonstrate adequate antibody response, as stated by the NIH 1, 2
Testing is only indicated for immunocompromised patients, according to the IDSA 3

The Centers for Disease Control and Prevention (CDC) recommends that interruptions in the vaccine schedule do not require restarting the entire series, as long as the patient eventually completes all four doses, according to the Advisory Committee on Immunization Practices (ACIP) 6, 7

The ACIP explicitly states that immunocompromised patients require a 5-dose regimen (days 0, 3, 7, 14, and 28) plus mandatory serologic testing 1-2 weeks after the final dose 6

The ACIP recommends that if HRIG was not given with the first dose on day 0, it can still be administered up to and including day 7 of the PEP series, but beyond day 7, HRIG should NOT be administered because vaccine-induced antibodies are presumed to have already developed 7, 8

The ACIP suggests considering serologic testing 7-14 days after completing the modified 4-dose series to confirm adequate antibody response (≥0.5 IU/mL by RFFIT), particularly if the patient is immunocompromised or if there are concerns about vaccine potency or administration technique 6, 7